These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 26787509)

  • 21. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus.
    Hoffman IE; Lauwerys BR; De Keyser F; Huizinga TW; Isenberg D; Cebecauer L; Dehoorne J; Joos R; Hendrickx G; Houssiau F; Elewaut D
    Ann Rheum Dis; 2009 Mar; 68(3):412-5. PubMed ID: 18930995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-NMDA receptor autoantibodies in patients with systemic lupus erythematosus and their first-degree relatives.
    Steup-Beekman G; Steens S; van Buchem M; Huizinga T
    Lupus; 2007; 16(5):329-34. PubMed ID: 17576734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies against N-methyl-D-aspartate receptors in patients with systemic lupus erythematosus without major neuropsychiatric syndromes.
    Kozora E; West SG; Maier SF; Filley CM; Arciniegas DB; Brown M; Miller D; Grimm A; Zhang L
    J Neurol Sci; 2010 Aug; 295(1-2):87-91. PubMed ID: 20546792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus.
    Isshi K; Hirohata S
    Arthritis Rheum; 1998 Oct; 41(10):1819-27. PubMed ID: 9778223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of gray matter volume between migraine and "strict-criteria" tension-type headache.
    Chen WT; Chou KH; Lee PL; Hsiao FJ; Niddam DM; Lai KL; Fuh JL; Lin CP; Wang SJ
    J Headache Pain; 2018 Jan; 19(1):4. PubMed ID: 29335889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus.
    Hanly JG; Urowitz MB; Su L; Bae SC; Gordon C; Clarke A; Bernatsky S; Vasudevan A; Isenberg D; Rahman A; Wallace DJ; Fortin PR; Gladman D; Romero-Diaz J; Sanchez-Guerrero J; Dooley MA; Bruce I; Steinsson K; Khamashta M; Manzi S; Ramsey-Goldman R; Sturfelt G; Nived O; van Vollenhoven R; Ramos-Casals M; Aranow C; Mackay M; Kalunian K; Alarcón GS; Fessler BJ; Ruiz-Irastorza G; Petri M; Lim S; Kamen D; Peschken C; Farewell V; Thompson K; Theriault C; Merrill JT
    Ann Rheum Dis; 2011 Oct; 70(10):1726-32. PubMed ID: 21893582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multimodal MRI approach to identify and characterize microstructural brain changes in neuropsychiatric systemic lupus erythematosus.
    Ercan E; Ingo C; Tritanon O; Magro-Checa C; Smith A; Smith S; Huizinga T; van Buchem MA; Ronen I
    Neuroimage Clin; 2015; 8():337-44. PubMed ID: 26106559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicentric prevalence study of anti P ribosomal autoantibodies in juvenile onset systemic lupus erythematosus compared with adult onset systemic lupus erythematosus.
    Pisoni CN; Muñoz SA; Carrizo C; Cosatti M; Álvarez A; Dubinsky D; Bresan E; Russo R; Borgia E; García M; Sansinanea P; Basta MC; D'Amico MA; Barreira JC; Lancioni E; Soriano E; Cunto Cd; Beron A; Eimon A
    Reumatol Clin; 2015; 11(2):73-7. PubMed ID: 24816340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of anti-acidic ribosomal protein P0 and anti-galectin 3 antibodies with the development of skin lesions in systemic lupus erythematosus.
    Shi ZR; Tan GZ; Meng Z; Yu M; Li KW; Yin J; Wei KH; Luo YJ; Jia SQ; Zhang SJ; Wu J; Mi XB; Wang L
    Arthritis Rheumatol; 2015 Jan; 67(1):193-203. PubMed ID: 25307291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-N-methyl-D-aspartate receptor antibodies are associated with fibromyalgia in patients with systemic lupus erythematosus: a case-control study.
    Park DJ; Takahashi Y; Kang JH; Yim YR; Kim JE; Lee JW; Lee KE; Lee JK; Lee SS
    Clin Exp Rheumatol; 2017; 35 Suppl 105(3):54-60. PubMed ID: 28339361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement.
    Trysberg E; Blennow K; Zachrisson O; Tarkowski A
    Arthritis Res Ther; 2004; 6(6):R551-6. PubMed ID: 15535833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of anti-NR2 and U1RNP antibodies with neurotoxic inflammatory mediators in cerebrospinal fluid from patients with neuropsychiatric systemic lupus erythematosus.
    Kondo-Ishikawa S; Fujii T; Ishigooka N; Murakami K; Nakashima R; Hashimoto M; Yoshifuji H; Tanaka M; Ohmura K; Mimori T
    Lupus; 2020 Nov; 29(13):1673-1682. PubMed ID: 32883159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgG anti-NR2 glutamate receptor autoantibodies from patients with systemic lupus erythematosus activate endothelial cells.
    Yoshio T; Okamoto H; Hirohata S; Minota S
    Arthritis Rheum; 2013 Feb; 65(2):457-63. PubMed ID: 23055186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Migraine and headache in systemic lupus erythematosus and their relationship with antibodies against phospholipids.
    Markus HS; Hopkinson N
    J Neurol; 1992 Jan; 239(1):39-42. PubMed ID: 1541968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. White-matter volume reduction and the protective effect of immunosuppressive therapy in systemic lupus erythematosus patients with normal appearance by conventional magnetic resonance imaging.
    Xu J; Cheng Y; Chai P; Lu Z; Li H; Luo C; Li X; Li L; Zhou Q; Chen B; Cao J; Xu X; Shan B; Xu L; Wen J
    J Rheumatol; 2010 May; 37(5):974-86. PubMed ID: 20231206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus.
    Husebye ES; Sthoeger ZM; Dayan M; Zinger H; Elbirt D; Levite M; Mozes E
    Ann Rheum Dis; 2005 Aug; 64(8):1210-3. PubMed ID: 15708887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Migrainous phenomena in systemic lupus erythematosus.
    Brandt KD; Lessell S
    Arthritis Rheum; 1978; 21(1):7-16. PubMed ID: 623696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
    Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease.
    Reichlin M; Broyles TF; Hubscher O; James J; Lehman TA; Palermo R; Stafford HA; Taylor-Albert E; Wolfson-Reichlin M
    Arthritis Rheum; 1999 Jan; 42(1):69-75. PubMed ID: 9920016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus.
    Yoshio T; Hirata D; Onda K; Nara H; Minota S
    J Rheumatol; 2005 Jan; 32(1):34-9. PubMed ID: 15630721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.